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Research
The passage of the Food Quality Protection 
Act (FQPA; 1996) has streamlined research 
efforts devoted to assessing exposure to 
organophosphorus (OP) pesticides. As a result, 
our understanding of OP exposures and asso-
ciated risk factors, particularly in children, has 
improved greatly (Fenske et al. 2002a; Koch 
et al. 2002; Lu et al. 2001, 2004, 2006, 2008; 
Whyatt and Barr 2001). However, our abil-
ity to use exposure measurements to estimate 
absorbed doses, which is essential for compar-
ing exposures to toxicologic benchmarks such 
as the reference dose (RfD), remains limited. 
A physiologically based pharmacokinetic 
(PBPK) model would permit simulation of the 
dynamics of chemical absorption, distribution, 
metabolism, and elimination (ADME) from dif-
ferent routes of exposures and, in theory, could 
be used as a tool for evaluating biomarker mea-
surements, such as blood or urine levels, that 
are associated with the exposures (Rigas et al. 
2001; Timchalk et al. 2002; Zhang et al. 2007). 
The mechanistic representation of biological 
processes embedded in PBPK models enables 
systematic route, dose, and species extrapola-
tion. For these reasons, PBPK models have been 
applied in chemical risk assessments (Blancato 
1994; Clewell et al. 2001) that are relevant for 
the interpretation of biomarker data. 
The objective of this study was to use a 
PBPK model to validate measures of urinary   
excretion of 3,5,6-trichloro-2-pyridinol 
(TCPY), which is the specific metabolite 
for chlorpyrifos (CPF), in young children. 
Exposure and urinary biomarker data used 
in this study were obtained from a pesticide 
exposure assessment study that was designed 
specifically to assess daily aggregate exposure 
to OP pesticides in children. We evaluated the 
use of the PBPK model for applying aggre-
gate exposure inputs and for estimating the 
cumulative urinary excretion with urinary bio-
markers. The PBPK model outputs, in the 
form of predicted cumulative urinary excre-
tion of TCPY in urine, were compared with 
the urinary TCPY levels measured in the four 
spot urine samples collected from each child. 
A consideration in the study design was that 
the results of the aggregate pesticide meas-
ure  ments would be of value for evaluating a 
PBPK-modeling approach by comparing the 
predicted and measured cumulative urinary 
metabolite excretion. 
Methods 
Child-specific PBPK model development. We 
initiated model development using PBPK 
models that were developed for CPF in rats 
and adult humans (Timchalk et al. 2002) in 
which CPF and chlorpyrifos oxon (CPFO) 
were modeled assuming circulation through 
physiologic well-mixed compartments. 
Metabolism of CPF (and CPFO) in the 
Timchalk et al. (2002) models was assigned to 
occur in the blood and liver, with the excreted 
metabolite, TCPY, lumped into a single com-
partment. To enable systematic extrapolation 
of the dose–urinary excretion behavior, we 
expanded the metabolite description from a 
volume-of-distribution concept to a physio-
logic description that can incorporate known 
differences at different life stages, such as 
between children and adults.
Physiologic parameters of the meta-
bolic compartments and the partition 
coefficients were estimated by the same com-
putational method (Poulin and Krishnan 
1995). Glucuronic conjugation and the urinary 
excretion rate parameters were based on TCPY 
data in rats (Timchalk et al. 2005) and in adult 
humans (Nolan et al. 1984). The rat model was 
first adapted and compared with the data, and 
human parameters were applied when known. 
In cases where a priori values were not avail-
able, rat parameters were scaled by body weight 
(BW) to establish an initial value that was then 
adjusted based on model fit. The parameters 
relevant to the physiologic description of the 
metabolite are shown in Table 1. Differences 
in physiology between rats and adult humans 
are generally well known, whereas the kinetic 
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Ba c k g r o u n d: A physiologically based pharmacokinetic (PBPK) model would make it possible to 
simulate the dynamics of chemical absorption, distribution, metabolism, and elimination (ADME) 
from different routes of exposures and, in theory, could be used to evaluate associations between 
exposures and biomarker measurements in blood or urine.
oB j e c t i v e: We used a PBPK model to predict urinary excretion of 3,5,6-trichloro-2-pyridinol 
(TCPY), the specific metabolite of chlorpyrifos (CPF), in young children.
Me t h o d s : We developed a child-specific PBPK model for CPF using PBPK models previously 
developed for rats and adult humans. Data used in the model simulation were collected from 
13 children 3–6 years of age who participated in a cross-sectional pesticide exposure assessment 
study with repeated environmental and biological sampling. 
re s u l t s: The model-predicted urinary TCPY excretion estimates were consistent with measured 
levels for 2 children with two 24-hr duplicate food samples that contained 350 and 12 ng/g of CPF, 
respectively. However, we found that the majority of model outputs underpredicted the measured 
urinary TCPY excretion.
co n c l u s i o n s: We concluded that the potential measurement errors associated with the aggregate 
exposure measurements will probably limit the applicability of PBPK model estimates for interpret-
ing urinary TCPY excretion and absorbed CPF dose from multiple sources of exposure. However, 
recent changes in organophosphorus (OP) use have shifted exposures from multipathways to 
dietary ingestion only. Thus, we concluded that the PBPK model is still a valuable tool for convert-
ing dietary pesticide exposures to absorbed dose estimates when the model input data are accurate 
estimates of dietary pesticide exposures. 
key w o r d s : chlorpyrifos, dietary pesticide exposure, PBPK, pesticide risk assessment, TCPY, urinary 
biomarker. Environ Health Perspect 118:125–130 (2010).  doi:10.1289/ehp.0901144 available via 
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constants were usually scaled by BW. The 
adaptations made to the adult PBPK model 
included modifications to the parameters for 
age, body volume, activity cardiac output, and 
alveolar ventilation rate. The cardiac output 
and alveolar ventilation rates were estimated 
using published equations (Price et al. 2003) 
and normalized to BW raised to the 3/4 power. 
The volumes for each individual tissue/organ 
were entered as a percentage of body volume, 
which was age adjusted. The parameters associ-
ated with the physiologic description of the 
metabolite in the child-specific PBPK model 
are shown in Table 2.
The rat, adult, and child PBPK mod-
els were implemented using the U.S. 
Enivironmental Protection Agency’s (U.S. 
EPA) Exposure Related Dose Estimating 
Model (ERDEM; Blancato et al. 2006). 
The ERDEM platform consists of two 
parts: the Microsoft Windows-based graphi-
cal user interface and the model engine, 
which is built in Advanced Continuous 
Simulation Language. The parameters for 
the study participants and for their exposure   
scenarios were created in ERDEM as the 
model data sets (MDSs) to ensure consis-
tent implementation and to facilitate review. 
The differential equations associated with 
the PBPK model are described online [see 
Supplemental Material available online 
(doi:10.1289/ehp.0901144.S1 via http://
dx.doi.org/). Zhang et al. (2007) successfully 
applied the ERDEM platform to develop the 
PBPK model for carbofuran, one of the cho-
linesterase-inhibiting carbamate insecticides. 
Human exposure data. The data used in 
the PBPK-model simulation were obtained 
from a cross-sectional pesticide exposure 
assessment study with repeated environmental 
and biologic sampling that was conducted 
in the U. S. state of Washington in 1998 
(Fenske et al. 2002b; Kissel et al. 2005; Lu 
et al. 2004). Participants were recruited from 
a pool of children who had been enrolled in 
two previous assessment studies of pesticide 
exposure in Washington State (Koch et al. 
2002; Lu et al. 2001). 
Children with elevated OP pesticide expo-
sure based on the measurements of urinary 
dialkylphosphate levels from these two studies 
were targeted for the present study to increase 
the probability that participants would have 
detectable OP residues in their home or diet. 
We saw this strategy as a more efficient use 
of limited research resources than randomly 
selecting from hundreds of children whose OP 
pesticide exposure might fall below the ana-
lytical limits of detection. In brief, the study 
was conducted in the homes of 13 children 
3–6 years of age who lived either in an urban 
or suburban area or in the agricultural region 
where OP pesticides were used in nearby fruit 
tree orchards. In 1998, each home was sam-
pled twice, once in the summer (June–August) 
and again in the fall (October). Samples col-
lected for exposure measurements included 
drinking water, outdoor soil, house dust, and 
toy wipe samples, in addition to indoor air 
and duplicate food samples over 24 hr. Four 
spot urine samples were collected over a 24-hr 
period (Figure 1). We selected CPF for mod-
eling because it was commonly found in the 
environmental samples and its metabolite, 
TCPY, was frequently detected in the urine 
samples. The study protocol and procedures to 
obtain the assent of the children and informed 
consent of their parents or guardians were 
reviewed and approved by the University of 
Washington Institutional Review Board. We 
obtained informed consent from the study 
participants before initiating the study.
Exposure scenarios. To account for the 
children’s aggregate exposure to CPF, each 
ERDEM/MDS was developed to allow data 
input for three concurrent exposure scenarios: 
bolus ingestion (based on levels measured in 
three meals throughout the sampling day), 
inhalation, and rate ingestion for nondietary 
routes (such as hand-to-mouth activity). 
The dermal route of exposure was not taken 
into account in the PBPK model simulation 
because CPF was not detected on any of the 
children’s hands at the time sampling was   
taking place.
Inhalation. Because 24-hr indoor air 
CPF concentrations were measured in a time-
weighted average manner, we activated the 
static lung subsystem, instead of breathing 
lung, in each ERDEM/MDS. This activation 
required the input of the percent volume for 
the lung tissue (Fisher et al. 1998) and for the 
relevant partition coefficients. The blood/lung 
partition coefficient was assumed to be equal 
to that of the rapidly perfused tissue (4.33), 
and the blood/air partition coefficient was set 
as the large default value (109) that represents 
nearly complete absorption (close to 100% 
because of the alveolar dead space) of inhaled 
OP pesticides and no exhalation of absorbed 
OP pesticides. These absorption characteris-
tics are consistent with the low volatility of 
OP pesticides. 
Rate ingestion. CPF exposure through 
the ingestion of contaminated soil and house 
dust was modeled as rate ingestion. The aver-
age daily rate of soil ingestion for children 
is 100 mg/day (U.S. EPA 2002a), and we 
assumed the same daily rate of house-dust 
ingestion for the PBPK/ERDEM simulations. 
Exposure through the ingestion of CPF resi-
due transferred from toys to a child’s hands 
Table 1. PBPK model parameters that describe 
physiologic TCPY in rats and adult humans.
Rat Adult human
Partition coefficients for TCPY
Brain:blood 23.027 15.89
Fat:blood 124.46 91.562
Kidney:blood 8.809 6.05
Liver:blood 9.648 9.95
Rapidly perfused:blood 7.452 3.94
Slowly perfused:blood 5.445 7.47
Partition coefficients for TCPY-g
Brain:blood 1.439 1.54
Fat:blood 6.14 0.221
Kidney:blood 1.103 1.16
Liver:blood 1.046 1.27
Rapidly perfused:blood 1.071 1.05
Slowly perfused:blood 1 1.13
Glucuronidation rate
Vmax3,4 (mmol/hr/kg0.75) 10 10
Kmm3,4 (mmol/L) 1 1
Saturable elimination
VmaxURN4 (mmol/hr/kg0.75) 10 0.74
KURN4 (mmol/L) 10 10
Parameters scaled by BW
Liver Vmax (mmol/hr/kg0.75)
CPF to CPF-ox 0.08 0.08
CPF to TCPY 0.273 0.273
CPF-ox to TCPY 74.4 74.4
Blood Vmax (mmol/hr/kg0.75)
CPF-ox to TCPY 57 57
GI absorption rate constant (per hr)
Stomach to portal blood 0.01 0.01a (0.01)b
Stomach to intestine 0.5 0.5a (0.5)b
Intestine to portal blood 0.5 0.1a (0.4)b
Intestine to feces 0 0.4a (0.1)b
aValues from Timchalk et al. (2002). bValues from Nolan 
et al. (1984). 
Table 2. Physiologic parameters used in the child-specific PBPK model.
Participant ID Age (years)a BW (kg)
Normalized cardiac 
output (L/H)b
Normalized alveolar 
ventilation rate (L/H)b
R1 4 15.5 23.94 14.24
R2 4 21.4 18.8 11.18
R3 4 14.5 25.17 14.98
R4 5 16.8 26.17 15.56
R5 3 13.4 22.1 13.34
R6 5 19.6c 23.31 13.86
S1 4 17.3 22.04 14.3
S2 6 18.2 27.83 16.68
S3 3 15 20.31 12.25
S4 4 15.5 23.94 14.98
S5 5 16.8 26.17 15.56
S6 6 22.7 23.58 14.14
S7 3 14.5 20.83 12.57
aAge rounded up to a whole year. bEquations in Price et al. (2003) were used to calculate rates of cardiac output and 
alveolar ventilation; results were divided by BW3/4. cStudy participant did not provide a BW; value taken from Exposure 
Factors Handbook, Table 11-3 (U.S. EPA 2002b). PBPK model for pesticide risk assessment
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and to the mouth was also modeled as rate 
ingestion. We assumed that each child played 
(indoors and outdoors) for 2–2.8 hr each day 
(U.S. EPA 2002a) and that 7 hand-to-mouth 
transfers occurred in each hour of play that 
resulted in a conservative estimate of 20 hand-
to-mouth activities while playing each day. 
We also assumed that 3% of the CPF residue 
measured on the child’s toy was transferred to 
the child’s hand after each contact (Clothier 
2000) and estimated the total daily ingestion 
of CPF from toys via hand-to-mouth activ-
ity by multiplying the CPF residue measured 
on the toy surface by 0.6 (20 hand-to-mouth 
transfers × 3%). 
Bolus ingestion. Duplicate food sam-
ples collected over 24 hr were combined to 
obtain a single meausre of dietary CPF intake 
over the sampling day. Although meals were 
knowingly consumed by the children at dif-
ferent time points throughout the day, dietary 
intake was modeled as a single bolus ingestion 
during dinner at 7 pm rather than continu-
ously throughout the day. This decision was 
made because of the way the 24-hr dupli-
cate food samples were composited to one 
large food sample for each child. Therefore, 
instead of arbitrarily spreading CPF residues 
meas  ured in the 24-hr duplicate food samples 
across different eating events, we minimized 
the artificial variability and assigned it to a 
single bolus ingestion at 7 pm each day.
Biological monitoring. The timing of spot 
urine collection was tailored to capture OP 
pesticides through all possible exposure path-
ways (Figure 1). The first spot sample was col-
lected before bedtime on the same day when 
the environmental and food sampling activi-
ties were completed (Day 1). Three additional 
spot urine samples were collected the next day 
(Day 2) during the first morning void, after 
lunch, and after dinner. 
The PBPK model simulation period was 
determined based on the biological half-life of 
CPF, which is between 16 and 30 hr depend-
ing on the route of exposure (Griffin et al. 
1999). Model simulations indicated that a half-
life of 24 hr was appropriate for aggregate sce-
narios, and the total exposure duration was set 
for 168 hr, equivalent to 7 half-lives of CPF. 
We initiated the model simulation at hr 0 to 
account for the body burden of CPF result-
ing from previous exposures via inhalation 
or ingestion of house dust or soil (Figure 1). 
The exposure scenario for food ingestion was 
started at the 24th hr of the model simulation. 
The rate ingestion exposure duration was set 
to represent 12 hr of exposure (while awake) 
and 12 hr without exposure (while sleeping 
and inactive) every 24 hr throughout the entire 
exposure duration (168 hr). 
PBPK model evaluation. The PBPK model 
outputs for each MDS included the predicted 
cumulative excretion of TCPY (mmol) in urine 
for the duration of exposure (168 hr), as well 
as the estimated absorbed dose for each MDS. 
The first 60-hr window of the model simulation 
was comparable to the actual urinary TCPY 
levels that were meas  ured in the four spot urine 
samples and was the window of interest for 
model evaluation because of its accuracy. The 
measured cumulative mass of TCPY excreted in 
urine was calculated by multiplying the volume-
weighted average of the four spot urine samples 
by 500 mL/day, the total daily urine excretion 
volume for children 2–5 years of age. 
The daily cumulative mass of TCPY in 
urine (mmol) =
  [Σ(Ci × Vi)/Σ(V )] × Vd,  [1]
where Ci = mass of TCPY measured in ith 
urine sample (millimoles per milliliter), 
Vi = volume of urine in the ith urine sample 
(milli  liter), and Vd = average daily urine excre-
tion volume (milli  liter).
The cumulative TCPY excretion measured 
at each urine sample collection time point was 
calculated for each participant, and compared 
with the distribution of the predicted cumula-
tive excretion of TCPY that was generated by 
the PBPK simulation. 
Model sensitivity analysis. A parameter 
sensitivity analysis was performed to identify 
important parameters associated with urinary 
TCPY excretion and tissue-specific CPF dose 
metrics that were important to model behav-
ior. A local analysis was applied, where the 
sensitivity coefficient =
  parameter
response
D
D ,
and the magnitude of the parameter change 
was 1% of the baseline value (Nestorov 1999; 
Simmons et al. 2002). Responses of interest 
included peak concentrations of CPF in blood 
and TCPY urinary excretion rates at 8 and 
24 hr after an oral CPF dose of 0.5 mg/kg. All 
model parameters were perturbed to investigate 
effects on model behavior.
Results
PBPK models for CPF. The adult human 
PBPK model simulations are compared with 
the available data in Figure 2. The PBPK-
based estimate of TCPY excretion was visually 
consistent with the published urinary data. 
This is critical for objectively interpreting uri-
nary TCPY levels using the PBPK model. The 
difference in urinary TCPY levels between 
these two sets of human data for oral exposure 
is likely due to different pesticide formulations 
used in the respective studies. Specifically, 
Nolan et al. (1984) administered CPF 
in a sugar cube after a light meal, whereas 
Timchalk et al. (2002) adminis  tered CPF in 
a tablet. The under  lying PBPK model descrip-
tions are the same except for behavior differ-
ences in the GI tract (Table 1). When only 
the GI parameters were varied across stud-
ies, the PBPK model results were consistent 
with CPF measured in blood and TCPY 
measured in urine. The results of the sensitiv-
ity analysis show important parameters that 
may impact the PBPK model simulation and 
outputs [see Supplemental Material, Table 1 
(doi:10.1289/ehp.0901144.S1)] and suggest 
that simplification of the full PBPK model to 
Day 1 Day 2
Breakfast 10 am Lunch 4 pm Dinner 8 pm
Before
bedtime
First
morning 10 am Lunch 4 pm Dinner 8 pm
A
F F F
U U U U
S, 
W HD
PBPK/ERDEM Simulationa
Exposure scenario 1b Exposure scenario 2c Exposure scenario 1b
0 hr 24th hour 48th hour 60th hour
Figure 1. Sampling schedule for the 1998 study (1) and the corresponding PBPK model simulation (2). Abbreviations: A, 24-hr indoor air; F, 24-hr duplicate diets; 
HD, house dust; S, soil; W, hand/toy wipe; U, spot urine. The arrow indicates a 24-hr sampling.
aModeled exposure duration for 168 hr; however, figure truncated after the 60th hr. bExposure scenario included rate ingestion and inhalation. cExposure scenario included rate ingestion, 
inhalation, and bolus food ingestion.  Lu et al.
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only evaluate urinary TCPY excretion is fea-
sible. These parameters reflect areas where it 
is important to know the differences between 
adults and children depending on the ques-
tions of interest. The large sensitivity coef-
ficients related to the tissue metrics generally 
correspond to metabolism and parameters 
associated with transport to active sites. In 
contrast, the TCPY urine excretion profile is 
strongly dependent only on the urine excre-
tion parameters. 
PBPK model predicted and measured 
cumulative urinary TCPY excretion. In the 
1998 study, the measured 24-hr cumulative 
urinary TCPY excretion among the 13 children 
ranged from 0 to 0.03 µmol (summer) and 
from 0.0025 to 0.063 µmol (fall) (Table 3). 
Excretions predicted by the PBPK model were 
consistently lower than the measured levels. 
However, the magnitude of underprediction, 
which was calculated as the predicted/observed 
TCPY excretion ratios, varied. In cases where 
CPF was only measured in a single matrix, 
such as in the 24-hr indoor air samples, the 
PBPK model simulations grossly underpre-
dicted cumulative TCPY excretion by as many 
as 7 orders of magnitude (participants S3-1, 
S4-1, S5-2, and S7-1). This discrepancy nar-
rowed to 2–3 orders of magnitude when CPF 
was detected in more than one sample matrix. 
In only two participants (S1-2 and S6-1) out 
of 26 cases in which CPF residues were also 
measured in the 24-hr duplicate food samples, 
the PBPK model predicted TCPY excretions 
approximate to the measured levels by 75% 
(Figures 3). We previously measured 350 and 
12 ng/g of CPF in two separate 24-hr duplicate 
food samples containing cherry tomatoes (S1-2) 
and a composite sample of apple and carrots 
(S6-1), respectively (Fenske et al. 2002b).
Absorbed dose estimates and comparisons 
with CPF benchmark dose. Overall, the PBPK 
model-predicted absorbed CPF dose was low 
among the study children. The two highest 
predicted doses (2.3 and 0.44 µg/kg/day) 
were associated with the two 24-hr dupli-
cate food samplings that contained 350 and 
12 ng/g CPF, respectively. For comparison, 
we used the measured 24-hr cumulative 
TCPY excretion (mmol/day), multiplying 
the molecular weight of CPF (350.6 ng/mol) 
and then dividing by the BW for each child 
(Table 2) to calculate a daily absorbed dose, 
assuming 1 mol CPF is metabolized to 1 mol 
TCPY that is then excreted unchanged in 
urine. In the absence of the PBPK models, 
this steady-state mass-balance approach is 
commonly used in converting urinary bio-
marker meas  urements to an absorbed dose. 
The magnitude of the discrepancy between 
the measured and the PBPK model-predicted 
urinary TCPY excretion levels carried over to 
the absorbed CPF dose estimation (Table 4). 
The calculated absorbed doses were generally 
higher than were their corresponding model- 
predicted values except for the estimates for 
the two children (S1-2 and S6-1) who con-
sumed food items containing CPF residues. 
Urban and suburban children had marginally 
higher daily CPF absorbed doses than did 
those living in the agricultural community 
(one-way ANOVA, p = 0.07). 
None of the predicted or calculated daily 
dose estimates exceeded the oral RfD of 
3 µg/kg/day, which is a toxicologic benchmark 
dose established by the U.S. EPA (2002a). 
However, when we took into consideration a 
safety factor of 10, as mandated by the FQPA 
for the purpose of protecting children from 
overexposure to pesticides, the child-specific 
RfD of 0.3 µg/kg/day would protect children 
at the 90th percentile based on the model-
predicted absorbed CPF doses and only at 
the 58th percentile level (11 of the 26 cases) 
using the steady-state mass-balance calculation 
approach. 
Table 3. Exposure data collected from 13 children 2–6 years of age in 1998 and their predicted and measured 24-hr cumulative TCPY excretions (µmol/day).
Participant ID
Sampling 
seasona
Toy  
(µg/sample)
Soil 
(µg/g)
Indoor air 
(µmol/m3)
House dust 
(µg/g)
Food 
(µg/day)
24-hr cumulative TCPY excretion 
Predicted Measured Ratio
R1 1 NA 0.025 0.01 0.28 0 3.6 × 10–5 1.6 × 10–2 2.2 × 10–3
2 0 0 0 0.28 0 3.3 × 10–5 2.7 × 10–2 1.2 × 10–3
R2 1 NA 0 0.001 0.28 0 3.0 × 10–5 6.7 × 10–3 4.5 × 10–3
2 0 0 0.001 0.28 0 3.0 × 10–5 5.2 × 10–3 5.9 × 10–3
R3 1 0 0 0 0.28 0 3.3 × 10–5 2.5 × 10–4 1.4 × 10–1
2 0.12 0 0.001 0.28 0 1.0 × 10–4 2.0 × 10–2 5.0 × 10–3
R4 1 NA 0 0.003 0.28 0 3.2 × 10–5 1.6 × 10–2 2.0 × 10–3
2 0 0 0.003 0.28 0 3.2 × 10–5 1.1 × 10–2 2.9 × 10–3
R5 1 NA 0 0.001 0.28 0 3.4 × 10–5 1.9 × 10–3 1.8 × 10–2
2 0.15 0 0.003 0.28 0 1.4 × 10–4 5.3 × 10–3 2.7 × 10–2
R6 1 NA 0.025 0.002 0.28 0 3.4 × 10–5 6.5 × 10–3 5.2 × 10–3
2 0.15 0 0.003 0.28 0 4.9 × 10–5 2.5 × 10–3 2.0 × 10–2
S1 1 NA 0 0.002 0.28 0 3.2 × 10–5 0 N.A
2 0 0 0.002 0 39.83 4.7 × 10–2 6.3 × 10–2 0.74
S2 1 NA 0.025 0.001 0 0 2.8 × 10–6 5.8 × 10–3 4.9 × 10–4
2 0 0 0.001 0.28 0 3.2 × 10–5 1.7 × 10–2 1.9 × 10–3
S3 1 NA 0 0.004 0 0 9.4 × 10–8 3.0 × 10–2 3.1 × 10–6
2 0 0 0.002 0.28 0 3.3 × 10–5 3.7 × 10–2 9.0 × 10–4
S4 1 NA 0 0.001 0 0 2.4 × 10–8 2.8 × 10–2 8.5 × 10–7
2 0 0 0 0 0 0 1.2 × 10–2 0
S5 1 NA 0.025 0.005 0.28 0 3.5 × 10–5 5.2 × 10–3 6.8 × 10–3
2 0 0 0.003 0 0 8.7 × 10–8 1.1 × 10–2 8.1 × 10–6
S6 1 NA 0 0.001 0 2.63 1.1 × 10–2 1.5 × 10–2 0.75
2 0.05 0 0.001 0 0 1.7 × 10–5 1.8 × 10–2 9.3 × 10–4
S7 1 NA 0 0.001 0 0 1.9 × 10–8 1.2 × 10–2 1.7 × 10–6
2 0.05 0 0.001 0.28 0 5.2 × 10–5 2.2 × 10–2 2.4 × 10–3
NA, not applicable.
aSampling season: 1, summer; 2, fall. 
Figure 2. Pharmacokinetic curves for TCPY (mmol) 
in urine following an oral dose of 0.5 mg/kg and 
dermal application of 5 mg/kg in humans. The lines 
are the PBPK model simulations compared with 
the oral data from Nolan et al. 1984 (square) and 
Timchalk et al. 2002a (diamond) and to the dermal 
data from Nolan et al. 1984 (triangle).
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Discussion 
The mechanistic nature of the PBPK model, 
including the process of linking exposure 
measurements of a toxic chemical to uri-
nary biomarker data and ultimately to the 
absorbed dose estimation, makes its applica-
tion favorable in risk assessment. It is impor-
tant, therefore, to realistically characterize 
the targeted activities and sources that would 
significantly contribute to exposure, which 
can subsequently be used as the PBPK model 
inputs. Incorrect assumptions, for example, 
that an individual’s absorbed dose entirely 
results from continuous sources and steady-
state levels, could attenuate the accuracy of 
model outputs.
In evaluating its use, it is apparent that 
the PBPK model has failed to predict TCPY 
excretion compared with the measured levels 
except for two children with dietary inges-
tion residues of CPF. This failure exposes 
the limitations of employing PBPK models 
for risk assessment in the absence of prior 
knowledge or high quality exposure data for 
model inputs. If physically measured urinary 
TCPY excretion in children is considered the 
gold standard measure of true exposure to 
CPF, the magnitude of underprediction by 
the PBPK model would be alarming. Several 
sources of errors could be attributed to the 
underperformance of the model. 
First, it is possible that the PBPK model 
that was developed under the ERDEM plat-
form is inadequate to simulate the ADME of 
CPF in children. However, we believe that 
this is not likely because our child-specific 
PBPK model was developed with parame-
ters derived from in vitro systems and was 
validated against two different human adult 
data sets (Figure 2). We believe that the dif-
ference of simulation outcomes between the 
two data sets was due to a difference in pes-
ticide formulations, which is irrelevant to the 
present study. The model sensitivity analysis 
showed that it was not the PBPK model but 
the urinary excretion rate that had the greatest 
impact on the dynamics of TCPY in urine. In 
addition, a similar PBPK/ERDEM model has 
been successfully applied to simulate one of 
the cholinesterase-inhibiting carbamate insec-
ticides (Zhang et al. 2007).
Second, the model underprediction high-
lights the ongoing discussion concerning the 
existence of preformed OP urinary metabolites 
in the environment and food that may con-
found the results of OP pesticide exposure and 
risk assessment (Morgan et al. 2005; Zhang 
et al. 2008). The preformed TCPY in the envi-
ronment and in foods may have artificially ele-
vated the overall CPF exposure. However, the 
magnitude of model underprediction could 
not be accounted for exclusively by this cause. 
We previously found that approximately 36% 
of the fortified mass of CPF was degraded in 
apple and orange juices (Lu et al. 2005). A 
similar magnitude of incomplete degradation 
of OPs in fresh fruits and vegetables was also 
documented in a recent article, which reported 
that the average molar-to-molar ratio between 
the OP pesticides and their metabolites was 
approximately 2:1 (Becker et al. 2006). If the 
amount of preformed TCPY had been taken 
into account before our PBPK simulations, 
the predicted urinary TCPY excretion would 
have been very close to the measured levels for 
the two children who were exposed to CPF via 
dietary intakes.
The last possible source of error, and the 
likely cause of the model underprediction of 
urinary TCPY excretion, is the quality of the 
exposure data used as model inputs. The aggre-
gate exposure assessment targeted at chemicals 
with short biologic half-lives, such as CPF, is 
prone to significant spatial and temporal varia-
tions that would result in inaccurate outcome 
measurements. Two observations from this 
study would support this conclusion. First, as 
previously discussed, by including the amount 
of preformed TCPY in the PBPK model simu-
lation; the model-predicted TCPY excretion 
was still not within a reasonable range of accu-
racy to the measured TCPY excretion. Second, 
the estimates underpredicted by the model 
were overwhelming, even though their cor-
responding measured TCPY levels in children, 
whose excretions were underestimated, were 
similar to the measured levels for the two chil-
dren with CPF residues in their 24-hr duplicate 
food samples that were close to the model pre-
dictions (Table 3). Apparently, CPF exposures 
in this group of children were not captured by 
the aggregate exposure assessment. This raises 
a serious question concerning the validity of 
applying aggregate exposure measurements as 
inputs for PBPK model simulation and sub-
sequent risk assessment. Because the exposure 
data were collected from a study that was spe-
cifically designed to validate the PBPK model 
simulation, we would expect this problem to 
be even more prevalent and dramatic when 
less-structured environmental exposure data are 
used as the model inputs.
Figure 3. The cumulative excretion difference of TCPY between measured urinary biomarker data and 
PBPK-predicted values for two study participants. (A) Participant S1-2 (Table 3) whose PBPK input 
included inhalation (indoor air) and single bolus ingestion (food intake). (B) Participant S6-1 (Table 3) 
whose PBPK input included inhalation (indoor air) and single bolus ingestion (food intake).
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Table 4. Descriptive statistics for measured, adjusted measured, and predicted daily dose (µg/kg/day) of 
CPF for 13 children 2–5 years of age, summer and fall,1998. 
Daily dose, summer 1998 Daily dose, fall 1998
Participant ID Calculateda Predictedb Calculateda Predictedb
R1 0.37 0.004 0.58 0.004
R2 0.11 0.003 0.08 0.003
R3 0.01 0.004 0.49 0.012
R4 0.33 0.003 0.23 0.003
R5 0.05 0.004 0.14 0.018
R6 0.12 0.003 0.04 0.005
S1 0 0.003 1.32 2.302
S2 0.11 < 0.001 0.33 0.003
S3 0.7 < 0.001 0.86 0.004
S4 0.64 < 0.001 0.38 < 0.001
S5 0.11 0.004 0.22 < 0.001
S6 0.23 0.440 0.28 0.001
S7 0.28 < 0.001 0.54 0.006
Descriptive statistics
Mean 0.24 0.04 0.42 0.18
SD 0.23 0.12 0.35 0.66
Percentile
5 < 0.0001 < 0.0001 0.04 < 0.0001
25 0.08 0.0001 0.18 0.0001
50 0.12 0.003 0.33 0.004
75 0.35 0.004 0.56 0.009
90 0.68 0.27 1.14 1.39
aCalculated daily dose using the mass balance equations and the measured 24-hr cumulative urinary TCPY excretion. 
bOutput from the PBPK/ERDEM simulation.Lu et al.
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The PBPK model simulations have many 
useful features, but absorbed dose estima-
tion is usually the ultimate application in 
risk assessment. Unfortunately, our results 
have demonstrated a potential pitfall of 
using a PBPK model as a tool for this pur-
pose. Minimizing the variability associated 
with aggregate exposure assessment of OPs 
is immense and difficult to accomplish. 
Nevertheless, the recent regulatory change of 
prohibiting residential use of CPF and other 
OPs (U.S. EPA 1998) may have alleviated 
the problem by eliminating the possibility of 
environmental exposures to OPs, except from 
the dietary ingestion route. The annual report 
from the Pesticide Data Program, adminis-
tered by the U.S. Department of Agriculture 
(USDA 2008) has confirmed the detection 
of OPs in common food commodities yearly, 
and recent studies have demonstrated that 
children are exposed to OP pesticides pre-
dominantly through dietary intakes (Lu et al. 
2006, 2008). The unique exposure pathway 
of OPs in food and the ability of the PBPK 
model to simulate dietary ingestion, as dem-
onstrated in this study, suggest that the PBPK 
model is still a valuable tool when the model 
input data reflect the best estimates of dietary 
OP exposures. Future improvement in assess-
ing dietary pesticide exposure and the con-
firmation of the degree of spontaneous OP 
pesticide degradation in foods should greatly 
enhance the utility of PBPK modeling for 
pesticide-dietary risk assessment.
Conclusions
We developed a child-specific PBPK model 
for CPF using models previously devel-
oped for rats and adult humans. The model 
was evaluated for its ability to predict uri-
nary TCPY excretion using environmental, 
food, and urine data that were obtained from 
13 children in a previous study. We found 
that the model underpredicted most of the 
cases except for two in which CPF residue 
was detected in the 24-hr duplicate food 
samples. Among the stipulated causes for the 
model’s poor performance, we believe that 
the potential measurement errors associated 
with aggregate exposure measurements are 
the most likely to affect the applicability of a 
PBPK model for interpreting urinary TCPY 
excretion and absorbed CPF dose estimates. 
The failure to predict TCPY excretion exposes 
the vulnerability of employing PBPK mod-
els for risk assessment without prior knowl-
edge or assurance of the quality of exposure 
data used for model inputs. Regardless, we 
concluded that the shift from OP exposure 
through multi  pathways to dietary ingestion 
exclusively has made the PBPK model a valu-
able tool for converting dietary pesticide expo-
sure to estimate absorbed dose estimates when 
model input data represent the best estimates 
of dietary-pesticide exposures.
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